| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.01 | 0.7 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.7 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.8 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |